D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
PGEN holding history
Precigen, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PGEN overviewAll 13F holders of PGENFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −424,900−100.0% | Sold out | Holders |
| Q4 2024 | 424,900 | $475.9K | <0.1% | −792,731−65.1% | Reduced | Holders |
| Q3 2024 | 1,217,631 | $1.15M | <0.1% | −511,311−29.6% | Reduced | Holders |
| Q2 2024 | 1,728,942 | $2.73M | <0.1% | −55,944−3.1% | Reduced | Holders |
| Q1 2024 | 1,784,886 | $2.59M | <0.1% | +775,439+76.8% | Added | Holders |
| Q4 2023 | 1,009,447 | $1.35M | <0.1% | +355,755+54.4% | Added | Holders |
| Q3 2023 | 653,692 | $928.2K | <0.1% | +50,947+8.5% | Added | Holders |
| Q2 2023 | 602,745 | $693.2K | <0.1% | −156,739−20.6% | Reduced | Holders |
| Q1 2023 | 759,484 | $805.1K | <0.1% | +13,000+1.7% | Added | Holders |
| Q4 2022 | 746,484 | $1.13M | <0.1% | +99,602+15.4% | Added | Holders |
| Q3 2022 | 646,882 | $1.37M | <0.1% | −149,964−18.8% | Reduced | Holders |
| Q2 2022 | 796,846 | $1.07M | <0.1% | −71,710−8.3% | Reduced | Holders |
| Q1 2022 | 868,556 | $1.83M | <0.1% | +788,222+981.2% | Added | Holders |
| Q4 2021 | 80,334 | $298.0K | <0.1% | +10,714+15.4% | Added | Holders |
| Q3 2021 | 69,620 | $347.0K | <0.1% | −172,887−71.3% | Reduced | Holders |
| Q2 2021 | 242,507 | $1.58M | <0.1% | −504,305−67.5% | Reduced | Holders |
| Q1 2021 | 746,812 | $5.15M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.